Compounds > cytarabine

cytarabine and 1 beta-d-arabinofuranosylcytosine 5'-diphosphate-l-1,2 dipalmitin

cytarabine has been researched along with 1 beta-d-arabinofuranosylcytosine 5'-diphosphate-l-1,2 dipalmitin in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19907 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berdel, WE; Danhauser-Riedl, S; Hong, CI; Okamoto, S; Rastetter, J; Vogler, WR; West, CR; Winton, EF1
An, SH; Buchheit, DJ; Hong, CI; Kirisits, AJ; Nechaev, A; Schliselfeld, L; West, CR1
An, SH; Berdel, WE; Buchheit, DJ; Hong, CI; Kirisits, AJ; Nechaev, A; West, CR1
Cerny, EA; Maccoss, M; Patel, KR; Rahman, YE1
Edwards, JJ; Lagocki, P; MacCoss, M; Rahman, YE1
Edwards, JJ; MacCoss, M; Seed, TM; Spragg, SP1
Hong, CI; MacCoss, M; Matsushita, T; Ryu, EK1

Other Studies

7 other study(ies) available for cytarabine and 1 beta-d-arabinofuranosylcytosine 5'-diphosphate-l-1,2 dipalmitin

ArticleYear
Therapeutic activity of 1-beta-D-arabinofuranosylcytosine conjugates of lipids in WEHI-3B leukemia in mice.
    Experimental hematology, 1989, Volume: 17, Issue:4

    Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line; Cytarabine; Drug Administration Schedule; Female; Injections, Intraperitoneal; Leukemia, Myeloid; Mice; Mice, Inbred BALB C; Neoplasm Transplantation

1989
Nucleoside conjugates. 10. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine 5'-diphosphate-1,2-dipalmitins.
    Journal of medicinal chemistry, 1988, Volume: 31, Issue:9

    Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Cytarabine; Drug Resistance; Drug Therapy; Leukemia L1210; Mice; Mice, Inbred DBA; Prodrugs; Stereoisomerism; Structure-Activity Relationship

1988
Nucleoside conjugates. 7. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of ether lipids.
    Journal of medicinal chemistry, 1986, Volume: 29, Issue:10

    Topics: Animals; Antineoplastic Agents; Cells, Cultured; Cytarabine; Drug Administration Schedule; Humans; Leukemia L1210; Leukemia P388; Mice; Mice, Inbred DBA; Solubility

1986
The treatment of intravenously implanted Lewis lung carcinoma with two sustained release forms of 1-beta-D-arabinofuranosylcytosine.
    European journal of cancer & clinical oncology, 1984, Volume: 20, Issue:8

    Topics: Animals; Antineoplastic Agents; Cytarabine; Delayed-Action Preparations; Female; Injections, Intraperitoneal; Injections, Intravenous; Liposomes; Lung Neoplasms; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Tissue Distribution

1984
Phospholipid-nucleoside conjugates. 5. The interaction of selected 1-beta-D-arabinofuranosylcytosine-5'-diphosphate-L-1,2-diacylglycerols with serum lipoproteins.
    Biochemical and biophysical research communications, 1983, Oct-31, Volume: 116, Issue:2

    Topics: Animals; Cytarabine; Dogs; Humans; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Macromolecular Substances; Temperature

1983
Phospholipid-nucleoside conjugates. The aggregational characteristics and morphological aspects of selected 1-beta-D-arabinofuranosylcytosine 5'-diphosphate-L-1,2-diacylglycerols.
    Biochimica et biophysica acta, 1982, Dec-17, Volume: 719, Issue:3

    Topics: Antineoplastic Agents; Cytarabine; Microscopy, Electron; Nephelometry and Turbidimetry; Structure-Activity Relationship; Temperature; Ultrasonics

1982
Phospholipid derivatives of nucleoside analogs as prodrugs with enhanced catabolic stability.
    Cancer research, 1981, Volume: 41, Issue:7

    Topics: Animals; Biotransformation; Cell Division; Cell Line; Cytarabine; Cytidine Diphosphate Diglycerides; Deamination; Delayed-Action Preparations; Injections, Intraperitoneal; Leukemia L1210; Mice; Neoplasm Transplantation; Prognosis; Ribonucleosides; Technology, Pharmaceutical; Tubercidin; Vidarabine

1981